General Information


DRACP ID  DRACP04166

Peptide Name  

Sequence  GWFDILKHVFRLLK

Sequence Length  14

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C88H134N22O17

Absent amino acids  ACEMNPQSTY

Common amino acids  L

Mass  200424

Pl  10.79

Basic residues  4

Acidic residues  1

Hydrophobic residues  8

Net charge  3

Boman Index  -645

Hydrophobicity  38.57

Aliphatic Index  132.14

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  423.08

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30506920

Title  Simulated Molecular Evolution for Anticancer Peptide Design

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17984

DRACP is developed by Dr.Zheng's team.